XTL Biopharmaceuticals Market Cap

XTL Biopharmaceuticals has a market cap or net worth of 36.14 million as of October 7, 2025. Its market cap has decreased by -69.25% in one year.

Market Cap

36.14M

Enterprise Value

32.48M

Revenue

1.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

4.00

Market Cap Chart

Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 36.14M, a decrease of -95.51%. That is a compound annual growth rate of -14.30%.

Market Cap History

Date	Market Cap	% Change
Oct 5, 2025	36.14M	-55.68%
Dec 31, 2024	81.53M	327.50%
Dec 31, 2023	19.07M	-14.63%
Dec 29, 2022	22.34M	-52.02%
Dec 30, 2021	46.56M	-7.60%
Dec 31, 2020	50.39M	108.51%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	75.93B
Danel (Adir Yeoshua)	3.00B
Kamada	1.31B
Bait Bakfar	974.87M
BrainsWay	961.20M
SofWave Medical	943.38M
Ilex Medical	714.47M
Novolog (Pharm-Up 1966)	661.07M

Market Cap Rankings